Nuanced Health

Nexilico

This company develops a computational discovery platform for precision microbiome engineering to help pharmaceutical firms and healthcare providers design targeted therapies and personalised treatments.

Fauna Bio

This company develops an artificial intelligence platform to identify drug targets for pharmaceutical partners by analysing genetic data from disease-resistant animal species.

Anto Biosciences

This company develops foundation models for microbial communities to predict drug toxicity and efficacy for pharmaceutical and biotechnology researchers.

BioCorteX

This digital medicine company develops a simulation platform to model drug-microbiome interactions for pharmaceutical and biotechnology clients to improve treatment outcomes.

Anto

This company develops foundation models to predict drug toxicity and efficacy by analysing gut microbiome data for pharmaceutical firms and drug developers.

Known Medicine

This company develops a platform using 3D cell culture and artificial intelligence to predict drug responses for oncologists and biopharmaceutical developers.

D2G Oncology

This company develops genomic drug screening platforms and mouse models to identify genotype-specific cancer treatments for healthcare institutions and pharmaceutical researchers.

Tessel Biosciences

The company develops artificial intelligence models and patient-derived virtual tissues to accelerate drug discovery for pharmaceutical and biotechnology organisations.